Caplans syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(18 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}
{{Caplans syndrome}}
{{Caplans syndrome}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{SharmiB}}
==Overview==
==Overview==
The exact pathogenesis of [disease name] is not fully understood.
[[Caplan's Syndrome|Caplan Syndrome]] is known as Rheumatoid [[pneumoconiosis]]. In patients with [[rheumatoid arthritis]], [[lungs]] show increased [[immune response]] to the foreign materials. In coal miners with RA, exposure to [[silica]] causes the release of different [[cytokines]] as [[interleukin-1]],[[granulocyte colony stimulating factor]] and [[tumor necrosis factor-alpha]] by [[monocytes]] and [[macrophages]]. [[Lymphocytes]] get activated by the [[cytokines]] and leading to hyperactive [[autoimmune]] response.
 
OR
 
It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
 
OR
 
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
 
OR
 
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
 
OR
 
 
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
 
OR
 
The progression to [disease name] usually involves the [molecular pathway].
 
OR
 
The pathophysiology of [disease/malignancy] depends on the histological subtype.
 
==Pathophysiology==
==Pathophysiology==
===Physiology===
The normal physiology of [name of process] can be understood as follows:
===Pathogenesis===
===Pathogenesis===
*The exact pathogenesis of [disease name] is not completely understood.
*It is understood that [[Caplan's Syndrome|syndrome]] is the result of alteration of [[immune response]] in the patients with [[Rheumatoid arthritis]].<ref name="SchreiberKoschel2010">{{cite journal|last1=Schreiber|first1=J.|last2=Koschel|first2=D.|last3=Kekow|first3=J.|last4=Waldburg|first4=N.|last5=Goette|first5=A.|last6=Merget|first6=R.|title=Rheumatoid pneumoconiosis (Caplan's syndrome)|journal=European Journal of Internal Medicine|volume=21|issue=3|year=2010|pages=168–172|issn=09536205|doi=10.1016/j.ejim.2010.02.004}}</ref>
OR
*There is an increased [[immune response]] to foreign materials in the [[lungs]].[[Silica]] initiates [[hyperactive immune responses]] in the [[coal miners]] with [[Rheumatoid arthritis]]
*It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
* [[Macrophages]] engulf [[silica |silica particles]], causing [[inflammation]] which eventually activate the [[fibroblast|firbroblasts]].  
*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
*Due to having [[apoptotic]] capacity, engulfed [[silica]] destroy the [[macrophages]] and again get taken up by another [[macrophage]]. This continued process activates [[chronic]] [[immune response]] and [[fibrosis]].
*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
*The progression to [disease name] usually involves the [molecular pathway].
*The pathophysiology of [disease/malignancy] depends on the histological subtype.


==Genetics==
==Genetics==
[Disease name] is transmitted in [mode of genetic transmission] pattern.
* No [[genetic association]] is found in Caplan Syndrome.
 
OR
 
Genes involved in the pathogenesis of [disease name] include:
*[Gene1]
*[Gene2]
*[Gene3]
 
OR
 
The development of [disease name] is the result of multiple genetic mutations such as:
 
*[Mutation 1]
*[Mutation 2]
*[Mutation 3]
 
==Associated Conditions==
==Associated Conditions==
Conditions associated with [disease name] include:
Conditions associated with [disease name] include:
*[[Rheumatoid Arthritis]] <ref name="SchreiberKoschel2010">{{cite journal|last1=Schreiber|first1=J.|last2=Koschel|first2=D.|last3=Kekow|first3=J.|last4=Waldburg|first4=N.|last5=Goette|first5=A.|last6=Merget|first6=R.|title=Rheumatoid pneumoconiosis (Caplan's syndrome)|journal=European Journal of Internal Medicine|volume=21|issue=3|year=2010|pages=168–172|issn=09536205|doi=10.1016/j.ejim.2010.02.004}}</ref>
*[[Silicosis]]
*[[Asbestosis]]


*[Condition 1]
==Gross Pathology==
*[Condition 2]
*[Condition 3]
==Overview==
==Pathophysiology==
===Gross Pathology===
Some people who have been exposed to the dust have severe lung scarring that makes it difficult for their lungs to carry oxygen to the bloodstream (called progressive massive [[fibrosis]]). People with [[rheumatoid arthritis]] do not seem more likely to have this complication of scarring.
Some people who have been exposed to the dust have severe lung scarring that makes it difficult for their lungs to carry oxygen to the bloodstream (called progressive massive [[fibrosis]]). People with [[rheumatoid arthritis]] do not seem more likely to have this complication of scarring.


Persons with rheumatoid arthritis are more likely to develop larger areas of [[inflammation]] and scarring in response to coal dust.
Persons with rheumatoid arthritis are more likely to develop larger areas of [[inflammation]] and scarring in response to coal dust.
==Microscopic Pathology==
==Microscopic Pathology==
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
[[Microscopic]] features of [[Caplan syndrome]] are
 
* [[Central]] [[necrotic]] area with  various amounts of [[collagen]] [[tissue]]. <ref name="GoughRivers1955">{{cite journal|last1=Gough|first1=J.|last2=Rivers|first2=D.|last3=Seal|first3=R. M. E.|title=Pathological Studies of Modified Pneumoconiosis in Coal-miners with Rheumatoid Arthritis (Caplan's Syndrome)|journal=Thorax|volume=10|issue=1|year=1955|pages=9–18|issn=0040-6376|doi=10.1136/thx.10.1.9}}</ref> <ref>{{cite journal|doi=10.1164/artpd.1958.78.2.274?journalCode=artpd}}</ref>
==References==
* Few [[nuclei]] might be found in the [[central]] [[necrotic]] area.
{{Reflist|2}}
* Outside of the [[necrotic]] area there are alternate layers of black coal [[dust]] and [[necrotic]] [[tissue]].
* Surrounding the dust ring, there is a zone of [[inflammation]] containing [[granulocytes]], [[macrophages]], and [[giant cells|giant cells]]. [[Macrophages]] might contain some [[dust]] particles.
* Outside of the [[inflammatory]] zone, there are some palisading [[cells]].


{{WH}}
{{WS}}
[[Category: (name of the system)]]
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 02:05, 21 June 2021

Caplans syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Caplans syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Caplans syndrome pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Caplans syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Caplans syndrome pathophysiology

CDC on Caplans syndrome pathophysiology

Caplans syndrome pathophysiology in the news

Blogs on Caplans syndrome pathophysiology

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Caplans syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sharmi Biswas, M.B.B.S

Overview

Caplan Syndrome is known as Rheumatoid pneumoconiosis. In patients with rheumatoid arthritis, lungs show increased immune response to the foreign materials. In coal miners with RA, exposure to silica causes the release of different cytokines as interleukin-1,granulocyte colony stimulating factor and tumor necrosis factor-alpha by monocytes and macrophages. Lymphocytes get activated by the cytokines and leading to hyperactive autoimmune response.

Pathophysiology

Pathogenesis

Genetics

Associated Conditions

Conditions associated with [disease name] include:

Gross Pathology

Some people who have been exposed to the dust have severe lung scarring that makes it difficult for their lungs to carry oxygen to the bloodstream (called progressive massive fibrosis). People with rheumatoid arthritis do not seem more likely to have this complication of scarring.

Persons with rheumatoid arthritis are more likely to develop larger areas of inflammation and scarring in response to coal dust.

Microscopic Pathology

Microscopic features of Caplan syndrome are

References

  1. 1.0 1.1 Schreiber, J.; Koschel, D.; Kekow, J.; Waldburg, N.; Goette, A.; Merget, R. (2010). "Rheumatoid pneumoconiosis (Caplan's syndrome)". European Journal of Internal Medicine. 21 (3): 168–172. doi:10.1016/j.ejim.2010.02.004. ISSN 0953-6205.
  2. Gough, J.; Rivers, D.; Seal, R. M. E. (1955). "Pathological Studies of Modified Pneumoconiosis in Coal-miners with Rheumatoid Arthritis (Caplan's Syndrome)". Thorax. 10 (1): 9–18. doi:10.1136/thx.10.1.9. ISSN 0040-6376.
  3. . doi:10.1164/artpd.1958.78.2.274?journalCode=artpd. Missing or empty |title= (help)